Acadian Asset Management LLC Pharma Cyte Biotech, Inc. Transaction History
Acadian Asset Management LLC
- $28.7 Billion
- Q1 2024
A detailed history of Acadian Asset Management LLC transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,589 shares of PMCB stock, worth $7,393. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,589
Previous 4,789
25.06%
Holding current value
$7,393
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PMCB
# of Institutions
32Shares Held
1.07MCall Options Held
5.4KPut Options Held
400-
K2 Principal Fund, L.P. Toronto, A6328KShares$674,6560.27% of portfolio
-
Geode Capital Management, LLC Boston, MA200KShares$412,5780.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA175KShares$359,6800.0% of portfolio
-
Ayrton Capital LLC Westport, CT92.1KShares$189,6997.31% of portfolio
-
Equitec Proprietary Markets, LLC82.7KShares$170,4170.12% of portfolio
About PharmaCyte Biotech, Inc.
- Ticker PMCB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,750,100
- Market Cap $42.7M
- Description
- PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...